AXA Global Healthcare has announced it will be enhancing its IPMI plans from October 2017 to meet the fresh challenges in the International Private Medical Insurance market. These updates include improvements to key offerings such as the International Health Plan, and Global Protect Health Plan in Hong Kong.
Enhancements have been made across several areas of cover, including policy limits on the Standard and Prestige Plus plans, improved ambulance transport benefit and an increased drugs and dressings and out-patient limit. Additionally, AXA is also introducing two new excess options to its Standard plan to give individual customers more options to tailor their premiums.
Kevin Melton, Director of Sales and Marketing commented, “We’re always reviewing our global health insurance propositions to make sure we can offer our customers the service and cover they need to live their life to the fullest. The global healthcare market is always evolving, and that’s why we’ve updated our proposition to ensure it can better meet the needs of our customers, wherever they are in the world. Whether they want a comprehensive health plan or cover in an emergency, we hope that these enhancements will provide the extra flexibility our customers require, so they have complete confidence in their plan.”
Key changes include:
- Overall policy limit – AXA has increased its overall annual policy limit on Standard and Prestige Plus, to offer customers additional confidence that its plans can cover them for the treatment they may need.
- Out-patient combined limit – treatment cost varies by country. So to ensure customers can continue to get the most out of their Comprehensive and Prestige plans, AXA has increased its out-patient limit which covers diagnostic tests as well as physiotherapy, and visits to a doctor.
- Ambulance transport – by removing the limit for ambulance transportation across all levels of cover, AXA now covers the cost of ambulance transport in full for its customers. Based on market analysis, AXA identified this as a key area of improvement for customers.
- New excess options – AXA understands that individual clients who choose the Standard International Health Plan are often happy to pay for day-to-day medical costs themselves, but still want cover for any serious or emergency treatment. AXA has therefore introduced two higher excess options on the Standard plan without out-patient cover. This option can also help manage premiums for any individual customers who are concerned about price increases.
- Drugs and dressings benefit – AXA has listened to feedback from members and increased the drugs and dressings limit on Comprehensive and Prestige plans.
The product enhancements also cover country-specific plans, including the Global Protect Health Plan, available to large corporate clients in Hong Kong.
Kevin Melton concluded, “These enhancements along with the our core offerings which include a second opinion service and evacuation and repatriation as standard means that customers can rest assured that with AXA, we’ll be there to help them whenever they need us.”
- Now Health International Launches New Digital IPMI Product To Cater For The Next Generation Of Expatriate
- Combatting Fraud, Waste And Abuse In IPMI
- New Range Of iPMI Plans Launched For The Russian Market
- Care Plus Launches International Private Medical Insurance (IPMI) Plan In Brazil
- Video: AXA Half Year 2017 Earnings Interview with Thomas Buberl, CEO of AXA
- AXA Strengthens International Healthcare Proposition For Growing Businesses
- Now Health International Reveals Top Twenty International Private Medical Insurance (iPMI) Claim Diagnoses
- New Force In International Private Health Insurance Launched
- Anthem Expands Affordable Mountain Health Plan To Small And Large Employers
- Insurers risk being sidelined by internet-savvy consumer generation
Latest from iPMI Magazine
- A.M. Best Upgrades Credit Ratings Of General De Salud Compañía De Seguros S.A.
- Hurricane Michael Likely Will Take Bigger Toll On Reinsurers
- AXIS Re Welcomes Ann Haugh As President Of Global Markets
- UnitedHealth Group Reports Third Quarter Results
- Medix Survey Uncovers Hong Kong’s Fear And Confusion Around Cancer